Health Care · Laboratory Analytical Instruments · Nasdaq · CIK 1726445 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $2.08Day −2.80%Mkt cap $114M1Y −4.6%Off 52W high −13.7%Vol (1Y) 56.5%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,360 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.3% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)−4.55% |
| Top-10 13F concentration80.1% |
| Next report (est.)2026-08-12 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$15.2M |
| Earnings (TTM)-$70.5M |
| ROE−25.1% |
| Net margin−444.0% |
| ROIC−24.7% |
| Sales growth 3Y2.3% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+13.7% |
| 1Y−4.6% |
| 3Y−58.9% |
| 5Y−93.6% |
| Since incept. (ann.)−45.7% |
Total return through 2026-07-29 · series begins 2021-02-22. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)56.5% |
| Ann. volatility (3Y)57.5% |
| Sharpe (1Y)0.16 |
| Sharpe (3Y)−0.22 |
| Max drawdown (1Y)−31.6% |
| Max drawdown (3Y)−70.9% |
| Beta (3Y vs SPY)1.47 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| SOFTBANK GROUP CORP. | 5.1M | $9M | 9.34% | +0.0% |
| Siren, L.L.C. | 2.5M | $4M | 4.47% | −38.5% |
| ACADIAN ASSET MANAGEMENT LLC | 2.1M | $3M | 3.77% | +1.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | $3M | 3.56% | new |
| BlackRock, Inc. | 1.8M | $3M | 3.31% | −0.3% |
| RENAISSANCE TECHNOLOGIES LLC | 976,688 | $2M | 1.78% | −7.1% |
| AJU IB Investment Co., Ltd. | 816,375 | $2M | 1.48% | +0.0% |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 825,000 | $1M | 1.50% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-13 | — | — | $2.8M | −33.6% |
| 2025-12-31 | 2026-02-26 | — | — | $4.2M | +5.0% |
| 2025-09-30 | 2025-11-06 | — | — | $4.1M | +2.2% |
| 2025-06-30 | 2025-08-06 | — | — | $4.1M | +31.9% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-12 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.